financetom
Business
financetom
/
Business
/
Novo Nordisk's Ozempic Gets FDA Approval for Kidney Disease
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Novo Nordisk's Ozempic Gets FDA Approval for Kidney Disease
Jan 28, 2025 12:22 PM

02:53 PM EST, 01/28/2025 (MT Newswires) -- Novo Nordisk ( NVO ) said Tuesday the US Food and Drug Administration approved its Ozempic to reduce the risk of kidney failure, worsening kidney disease and death due to cardiovascular disease in adults with Type 2 diabetes and chronic kidney disease.

Price: 86.01, Change: -1.50, Percent Change: -1.71

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Airbus delivered 507 jets in first nine months
Airbus delivered 507 jets in first nine months
Oct 8, 2025
PARIS, Oct 8 (Reuters) - Airbus said on Wednesday it had delivered 507 jets in the first nine months, leaving 313 more airplanes to deliver in the fourth quarter to reach a full-year target of around 820. The world's largest planemaker confirmed a Reuters report that it had delivered 73 jets in September, a record for that month of the...
CervoMed Drug Cut Dementia Progression Risk By 75% In Trial
CervoMed Drug Cut Dementia Progression Risk By 75% In Trial
Oct 8, 2025
CervoMed Inc. ( CRVO ) on Wednesday shared additional data from its Phase 2b RewinD-LB trial of neflamapimod for dementia with Lewy bodies (DLB). The results are based on the final analyses of the RewinD-LB trial, conducted after the August 2025 database lock for the full 48-week trial (16 weeks placebo-controlled (Initial Phase), followed by a 32-week neflamapimod-only extension (Extension...
Geomega Resources Jumps 6.9% on Rio Tinto Partnership for Bauxite Residue Valorization Technology
Geomega Resources Jumps 6.9% on Rio Tinto Partnership for Bauxite Residue Valorization Technology
Oct 8, 2025
11:55 AM EDT, 10/08/2025 (MT Newswires) -- Geomega Resources ( GOMRF ) shares rose 6.9% Wednesday after it said its wholly owned unit, Innord, entered into a Joint Development Agreement (JDA) with Rio Tinto in connection with Geomega's Bauxite Residue Valorization Technology. The company said the JDA includes Rio Tinto purchasing a demonstration license for Circuit 1 and 2 of...
Former top producer South Africa rues lost glitter as gold price spikes
Former top producer South Africa rues lost glitter as gold price spikes
Oct 8, 2025
Oct 8 (Reuters) - South African mining veteran Duncan Wanblad on Wednesday lamented the country's foregone investment in mining, as gold prices surged past $4,000 an ounce - a record high driven by expectations of lower interest rates and safe-haven demand. Addressing the Johannesburg Mining Indaba conference, Anglo American Plc ( AAUKF ) CEO Duncan Wanblad, whose company exited South...
Copyright 2023-2026 - www.financetom.com All Rights Reserved